Bonenta to Present at the BIO 2009 International Convention

Press kit materials are available online at
www.virtualpressoffice.com/kit/BonentaBIO09

Bonenta is developing novel drug-eluting synthetic bone grafts to provide safer,
cost effective alternatives to bone repair
BIRMINGHAM, Ala.--(Business Wire)--
Bonenta, Inc., a development stage biotechnology company dedicated to the
discovery, development and commercialization of novel bone healing products,
today announced that it will present at the BIO 2009 International Convention on
May 20, 2009, at 2:00 p.m. in room 315 at the Georgia World Congress Center in
Atlanta, GA.

"Bonenta`s platform technology holds enormous potential for the discovery of new
solutions for bone healing," said Dr. Arthur DeCarlo, President and CEO of
Bonenta. "Our lead product candidate, B247, a bone morphogenetic protein
co-activator, has exhibited enhanced bone healing capabilities in pre-clinical
testing and we look forward to presenting an overview of Bonenta to the
biotechnology business and scientific community at the BIO International
Convention."

About the BIO 2009 International Convention

Occurring May 18-21, 2009 in Atlanta, GA, the annual BIO (Biotechnology Industry
Organization) conference is considered to be a premiere global event for the
biopharmaceutical industry. Over 20,000 Biotechnology industry innovators,
business leaders, and decision makers from 60 or more countries will connect and
meet, and showcase the biotechnology industry and its global impact.
http://convention.bio.org/

About Bonenta

Bonenta is an emerging biotechnology company dedicated to the discovery, and
development of novel bone healing products. Bonenta`s drug-eluting synthetic
bone graft program is focused on producing safe, effective and cost-effective
bone healing solutions. Bonenta`s lead product candidate, B247, is a bone
morphogenetic protein co-activator being developed for use in spinal surgery,
bone repair and implants and oral/periodontal bone surgeries. Bonenta believes
its products have the potential to facilitate, safer, cost-effective, superior
bone healing. Additional information about Bonenta can obtained at
www.bonenta.com.

Red Mountain Communications
Jonathan M. Nugent
205-566-3026
jnugent@redmtncom.com

Copyright Business Wire 2009